■ Screening for diabetic retinopathy: strategies for improving patient follow-up
J B Skaggs, X Zhang, D J Olson et al
North Carolina Medical Journal 2017, vol 78: 121-123
http://www.ncmedicaljournal.com/content/78/2/121.full
■ Non-adherence to eye care in people with diabetes
Ann P Murchison, Lisa Hark, Laura T Pizzi et al
BMJ Open Diabetes Res Care. 2017; 5(1): e000333
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574424/
■ Diabetic retinopathy screening ratio is improved when using a digital, nonmydriatic fundus camera onsite in a diabetes outpatient clinic
Pia Roser, Hannes Kalscheuer, Jan B. Groener, Daniel Lehnhoff et al
J Diabetes Res. 2016; 2016: 4101890
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745285/
■ An innovative Australian outreach model of diabetic retinopathy screening in remote communities
Nicola M. Glasson, Lisa J. Crossland, Sarah L. Larkins
J Diabetes Res. 2016; 2016: 1267215
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698887/
■ Diabetic retinopathy screening and monitoring of early stage disease in Australian general practice: tackling preventable blindness within a chronic care model
Lisa Crossland, Deborah Askew, Robert Ware, Peter Cranstoun, Paul Mitchell, Andrew Bryett, Claire Jackson
J Diabetes Res. 2016; 2016: 8405395
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698989/
■ Diabetic retinopathy screening using telemedicine tools: pilot study in Hungary
Dóra J. Eszes, Dóra J. Szabó, Greg Russell et al
J Diabetes Res. 2016; 2016: 4529824
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204085/
■ The role of dyslipidemia control in the progression of diabetic retinopathy in patients with type 2 diabetes mellitus
Irini P. Chatziralli
Diabetes Ther. 2017 Apr; 8(2): 209–212
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380502/
■ Treatment strategies for chorioretinal vascular diseases: advantages and disabantages of individualized therapy
M W Stewart
EMJ Diabet 2016, vol 4 (1): 91-98
■ Fatores de risco e incidência da retinopatia diabética.
Mendanha, Denise Borges de Andrade et al.
Rev. bras.oftalmol., Dez 2016, vol.75, no.6, p.443-446
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802016000600443&lng=en&nrm=iso
■ Noninvasive retinal markers in diabetic retinopathy: advancing frombench towards bedsid
Søren Leer Blindbæk, Thomas Lee Torp, Kristian Lundberg et al
J Diabetes Res. 2017; 2017: 2562759.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406729/
■ The evaluation of ocular changes in prediabetic individuals
A Sokolowska-Oracz, P Piatkiewicz
Clinical Diabetology 2017, vol 6 (1): 8-16
https://journals.viamedica.pl/clinical_diabetology/article/view/DK.2017.0003/40758
■ Overview of ocular anti-vascular endothelial growth factor therapy in the management of diabetic eye complications
Oluwaranti Akiyode, Christine Tran
Diabetes Spectr. 2016 Feb; 29(1): 44–49
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755448/
■ Prevalence of undiagnosed diabetic retinopathy among inpatients with diabetes: the diabetic retinopathy inpatient study (DRIPS)
Jessica J Kovarik, Andrew W Eller, Lauren A Willard et al
BMJ Open Diabetes Res Care. 2016; 4(1): e000164
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761984/
■ Problem-solving therapy for adults with diabetic retinopathy and diabetes-specific distress: a pilot randomized controlled trial
Gwyneth Rees, Fleur O’Hare, Marian Saeed et al
BMJ Open Diabetes Res Care. 2017; 5(1): e000307
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304260/
■ Inpatient screening for albuminuria and retinopathy to p´redict long-term mortality in type 2 diabetic patients: a retrospective cohort study
Ya-Mei Hsieh, Wen-Jane Lee, Wayne H.-H. Sheu et al
Diabetol Metab Syndr. 2017; 9: 29
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415718/
■ Visual acuity, retinal sensitivity, and macular thickness changes in diabetic patients withou diabetic retinopathy after cataract surgery
Spela Stunf Pukl, Nataša Vidović Valentinčič, Mojca Urbančič et al
J Diabetes Res. 2017; 2017: 3459156
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294376/
■ Danish nationwide data reveal a link between diabetes mellitus diabetic retinopathy, and glaucoma
Anna Horwitz, Beáta Éva Petrovski, Christian Torp-Pedersen, Miriam Kolko
J Diabetes Res. 2016; 2016: 2684674
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107855/
■ Lower hemoglobin concentration is associated with retinal ischemia and the severity of diabetic retinopathy in type 2 diabetes
Alicia Traveset, Esther Rubinat, Emilio Ortega et AL
J Diabetes Res. 2016; 2016: 3674946
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855016/
■ Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies
C Merlotti, V Ceriani, A Morabito and A Pontiroli
Obesity Review 2017, vol 18 (3): 309-316
http://onlinelibrary.wiley.com/doi/10.1111/obr.12490/full
■ Diabetic retinopathy in Italy: epidemiology data and telemedicine screening programs
Stela Vujosevic, Edoardo Midena
J Diabetes Res. 2016; 2016: 3627465
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136623/
■ The adenosinergic system in diabetic retinopathy
- Vindeirinho, A. R. Santiago, C. Cavadas, A. F. Ambrósio, P. F. Santos
J Diabetes Res. 2016; 2016: 4270301.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789509/
■ Circulating biomarkers of diabetic retinopathy: an overview based on physiopathology
Olga Simó-Servat, Rafael Simó, Cristina Hernández
J Diabetes Res. 2016; 2016: 5263798
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916280/
■ Neuroprotection as a therapeutic target for diabetic retinopathy
Cristina Hernández, Massimo Dal Monte, Rafael Simó, Giovanni Casini
J Diabetes Res. 2016; 2016: 9508541
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830713/
■ Incretin-based therapy for prevention of diabetic vascular complications
Akira Mima
J Diabetes Res. 2016; 2016: 1379274
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735992/
■ Diabetic macular edema pathophysiology: vasogenic versus inflammatory
Pedro Romero-Aroca, Marc Baget-Bernaldiz, Alicia Pareja-Rios et al
J Diabetes Res. 2016; 2016: 2156273
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059543/
■ Influence of age at diagnosis and time-dependent risk factors on the development of diabetic retinopathy in patient with type 1 diabetes
Luis Forga, María José Goñi, Berta Ibáñez et AL
J Diabetes Res. 2016; 2016: 9898309
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861784/
■ Evaluation of cytokines in type 1 diabetes patients with and without retinopathy
Cardoso, Jéssica F. et al.
- Bras. Patol. Med. Lab., Feb 2017, vol.53, no.1, p.31-37
■ Influence of the epiretinal membrane on ranibizumab therapy outcomes in patients with diabetic macular edema
Ercalik, Nimet Yesim et al.
Arq. Bras. Oftalmol., Dec 2016, vol.79, no.6, p.373-37
■ Corneal backscatter in insulin-dependent and non-insulin-dependent diabetes mellitus patients: a pilot study
Calvo-Maroto, Ana M et al.
Arq. Bras. Oftalmol., June 2017, vol.80, no.3, p.148-153
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492017000300148&lng=en&nrm=iso
■ Comparison between multi-spot laser and conventional laser in treatment of diabetic clinically significant macular edema
Elsawah, Kareem Mohsen et al.
Rev. bras.oftalmol., Aug 2017, vol.76, no.4, p.175-180
■ Fatores de risco associados à intervenção com injeção intravítrea de anti-VEGF em pacientes com edema macular diabético
Faria, Aline Roseane Queiroz de Paiva, Lima Neto, Eufrasio de Andrade and Silva, Cesar Cavalcanti da
Rev. bras.oftalmol., Jun 2017, vol.76, no.3, p.121-127
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802017000300121&lng=en&nrm=iso
■ Actualización de la retinopatia diabética para médicos de atención primaria: hacia uma mejora de la medicina telemátic
J E Muñoz de Escalona-Rojas, A Quereda-Castañeda, O García-Garcia
Semergen 2016;42:172-6
■ Early diagnosis of diabetic retinopathy in primary care.
Jiménez-Báezez, Maria Valeria et al.
Colomb. Med., Mar 2015, vol.46, no.1, p.14-18
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657-95342015000100004&lng=en&nrm=iso
■ by Dr Paulo Fernando Leite
Cardiologia – Centro Médico Unimed BH
Rua Gonçalves Dias 202
Belo Horizonte/MG/Brasil
31 30033306 / 40204020
CRMMG: 7026
Email: pfleite1873@gmail.com